EA201791456A1 - Пептиды-антагонисты cgrp - Google Patents

Пептиды-антагонисты cgrp

Info

Publication number
EA201791456A1
EA201791456A1 EA201791456A EA201791456A EA201791456A1 EA 201791456 A1 EA201791456 A1 EA 201791456A1 EA 201791456 A EA201791456 A EA 201791456A EA 201791456 A EA201791456 A EA 201791456A EA 201791456 A1 EA201791456 A1 EA 201791456A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peptide antagonists
cgrp peptide
cgrp
compounds
formula
Prior art date
Application number
EA201791456A
Other languages
English (en)
Other versions
EA032082B1 (ru
Inventor
Казимеж ВИСНЕВСКИ
Гуанчэн ЦЗЯН
Александр К Рабинович
Хавьер Х Суэирас-Диас
Original Assignee
Ферринг Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ферринг Б.В. filed Critical Ферринг Б.В.
Publication of EA201791456A1 publication Critical patent/EA201791456A1/ru
Publication of EA032082B1 publication Critical patent/EA032082B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)

Abstract

Данное изобретение относится к соединениям формулы (I) или их фармацевтически приемлемой солигде m, p, A, Ar, Ar, Ar, R, Rи Rявляются такими, как определено в описании изобретения. Соединения формулы (I) могут быть использованы в качестве антагонистов пептида, связанного с геном кальцитонина (CGRP), и могут быть использованы для лечения.
EA201791456A 2015-01-06 2016-01-06 Пептиды-антагонисты cgrp EA032082B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562100371P 2015-01-06 2015-01-06
PCT/EP2016/050110 WO2016110499A1 (en) 2015-01-06 2016-01-06 Cgrp antagonist peptides

Publications (2)

Publication Number Publication Date
EA201791456A1 true EA201791456A1 (ru) 2018-01-31
EA032082B1 EA032082B1 (ru) 2019-04-30

Family

ID=55071041

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201791456A EA032082B1 (ru) 2015-01-06 2016-01-06 Пептиды-антагонисты cgrp

Country Status (34)

Country Link
US (1) US9969775B2 (ru)
EP (1) EP3242882B1 (ru)
JP (1) JP6929227B2 (ru)
KR (1) KR20170102302A (ru)
CN (1) CN107207567B (ru)
AR (1) AR103499A1 (ru)
AU (1) AU2016206059B2 (ru)
BR (1) BR112017013413A2 (ru)
CA (1) CA2973041A1 (ru)
CL (1) CL2017001761A1 (ru)
CO (1) CO2017007940A2 (ru)
DK (1) DK3242882T3 (ru)
EA (1) EA032082B1 (ru)
ES (1) ES2924410T3 (ru)
HR (1) HRP20220941T1 (ru)
HU (1) HUE059379T2 (ru)
IL (1) IL252903B (ru)
JO (1) JO3669B1 (ru)
LT (1) LT3242882T (ru)
MA (1) MA41311B1 (ru)
MD (1) MD3242882T2 (ru)
MX (1) MX2017008893A (ru)
MY (1) MY196439A (ru)
PH (1) PH12017501214A1 (ru)
PL (1) PL3242882T3 (ru)
PT (1) PT3242882T (ru)
RS (1) RS63467B1 (ru)
SA (1) SA517381865B1 (ru)
SG (1) SG11201705306UA (ru)
SI (1) SI3242882T1 (ru)
TN (1) TN2017000248A1 (ru)
TW (1) TWI717331B (ru)
UA (1) UA121490C2 (ru)
WO (1) WO2016110499A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018362018A1 (en) * 2017-11-06 2020-06-25 Auckland Uniservices Limited Peptide conjugate CGRP receptor antagonists and methods of preparation and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268474B1 (en) * 1998-04-30 2001-07-31 Creighton University Peptide antagonists of CGRP-receptor superfamily and methods of use
TW200533398A (en) 2004-03-29 2005-10-16 Bristol Myers Squibb Co Novel therapeutic agents for the treatment of migraine
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
AU2005294448B2 (en) * 2004-10-07 2011-07-14 Merck Sharp & Dohme Corp. CGRP receptor antagonists
CN101107264A (zh) * 2005-01-17 2008-01-16 捷瑞尼股份公司 C5a受体拮抗剂
EP1861399B1 (en) * 2005-03-14 2011-12-14 Merck Sharp & Dohme Corp. Cgrp receptor antagonists
US8168592B2 (en) * 2005-10-21 2012-05-01 Amgen Inc. CGRP peptide antagonists and conjugates
ES2664854T3 (es) * 2005-11-14 2018-04-23 Teva Pharmaceuticals International Gmbh Anticuerpos antagonistas dirigidos contra un péptido relacionado con el gen de la calcitonina para tratar cefalea en racimos
AU2007258294A1 (en) * 2006-06-13 2007-12-21 Vertex Pharmaceuticals Incorporated CGRP receptor antagonists
CN108997490A (zh) * 2012-01-26 2018-12-14 克里斯托弗·J·索尔斯 肽激素的降钙素cgrp家族的肽拮抗剂和它们的用途

Also Published As

Publication number Publication date
MX2017008893A (es) 2017-10-25
SG11201705306UA (en) 2017-07-28
SA517381865B1 (ar) 2021-09-15
PH12017501214A1 (en) 2018-01-08
SI3242882T1 (sl) 2022-09-30
HRP20220941T1 (hr) 2022-10-28
AU2016206059A1 (en) 2017-07-20
RS63467B1 (sr) 2022-08-31
KR20170102302A (ko) 2017-09-08
HUE059379T2 (hu) 2022-11-28
WO2016110499A1 (en) 2016-07-14
TWI717331B (zh) 2021-02-01
EP3242882B1 (en) 2022-05-04
PT3242882T (pt) 2022-08-09
AU2016206059B2 (en) 2019-07-25
MD3242882T2 (ro) 2022-10-31
BR112017013413A2 (pt) 2018-01-09
MY196439A (en) 2023-04-11
UA121490C2 (uk) 2020-06-10
LT3242882T (lt) 2022-08-25
IL252903A0 (en) 2017-08-31
MA41311A (fr) 2017-11-14
CN107207567B (zh) 2021-11-23
CN107207567A (zh) 2017-09-26
CO2017007940A2 (es) 2017-10-31
ES2924410T3 (es) 2022-10-06
EP3242882A1 (en) 2017-11-15
US9969775B2 (en) 2018-05-15
DK3242882T3 (en) 2022-08-08
US20180002378A1 (en) 2018-01-04
EA032082B1 (ru) 2019-04-30
PL3242882T3 (pl) 2022-10-31
CA2973041A1 (en) 2016-07-14
AR103499A1 (es) 2017-05-17
CL2017001761A1 (es) 2018-01-26
JP2018505213A (ja) 2018-02-22
JP6929227B2 (ja) 2021-09-01
TW201630929A (zh) 2016-09-01
TN2017000248A1 (en) 2018-10-19
IL252903B (en) 2021-01-31
JO3669B1 (ar) 2020-08-27
MA41311B1 (fr) 2022-10-31

Similar Documents

Publication Publication Date Title
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
EA201891024A1 (ru) Соединения-ингибиторы tank-связывающей киназы
EA201792205A1 (ru) Гетероциклические соединения как ингибиторы lsd1
EA202091115A1 (ru) Производные хиназолина, применяемые для лечения вич
CL2015000942A1 (es) Compuestos de benceno sustituido.
EA201791420A1 (ru) Соединения триазолопиримидина и их применения
EA201692203A1 (ru) Соединения, ингибирующие tank-связывающую киназу
EA201790170A1 (ru) Терапевтические соединения-ингибиторы
CL2016003422A1 (es) Inhibidores de demetilasa-1 específico de lisina
EA201692316A1 (ru) Производные холана для применения при лечении и/или профилактике fxr и tgr5/gpbar1-опосредованных заболеваний
EA201791576A1 (ru) Ингибитор jak
EA201791305A1 (ru) Конденсированные пиримидины для лечения вич
CL2016002072A1 (es) 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer
CL2014001858A1 (es) Compuestos derivados de pirrolidina-2-carboxamidas sustituidas, antagonistas de mdm2; composicion farmacetica; y su uso en el tratamiento o profilaxis del cancer.
CL2016003423A1 (es) Inhibidores de demetilasa-1 específico de lisina
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
CL2015002897A1 (es) Inhibidores de bace1
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
EA201791174A1 (ru) Антимикотическое соединение
NO20180002A1 (en) Aminobenzisoxazole compounds as agonists of A7-nicotinic acetylcholine receptors
CL2016002839A1 (es) Derivados de carboxamida
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201890364A1 (ru) СОЕДИНЕНИЯ, ПРИГОДНЫЕ ДЛЯ ИНГИБИРОВАНИЯ ROR-ГАММА-t

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): TJ TM